Kalray S.A. (LON:0ABT)
 1.060
 +0.040 (3.92%)
  At close: Oct 30, 2025
Kalray Revenue
Kalray had revenue of 12.73M EUR in the half year ending June 30, 2025, a decrease of -39.15%. This brings the company's revenue in the last twelve months to 38.20M, up 2.45% year-over-year. In the year 2024, Kalray had annual revenue of 44.10M with 10.38% growth.
Revenue (ttm) 
 38.20M EUR
Revenue Growth 
 +2.45%
P/S Ratio 
 0.37
Revenue / Employee 
 169.77K EUR
Employees 
 225
Market Cap 
11.97M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 44.10M | 4.15M | 10.38% | 
| Dec 31, 2023 | 39.95M | 9.33M | 30.45% | 
| Dec 31, 2022 | 30.63M | 18.41M | 150.62% | 
| Dec 31, 2021 | 12.22M | 3.61M | 41.90% | 
| Dec 31, 2020 | 8.61M | 1.13M | 15.10% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| Shell | 198.54B | 
| BP p.l.c. | 134.89B | 
| Unilever | 51.24B | 
| HSBC Holdings | 43.13B | 
| AstraZeneca | 41.24B | 
| Rio Tinto Group | 39.22B | 
| GSK plc | 31.63B | 
| British American Tobacco p.l.c. | 25.60B |